YWHAB knockdown inhibits cell proliferation whilst promoting cell cycle arrest and apoptosis in colon cancer cells through PIK3R2

Zhou,Xin; Chen,Aijun; Zhang,Tingting

doi:10.3892/etm.2023.11892

YWHAB knockdown inhibits cell proliferation whilst promoting cell cycle arrest and apoptosis in colon cancer cells through PIK3R2

Authors:
- Xin Zhou
- Aijun Chen
- Tingting Zhang
View Affiliations

Affiliations: Department of Gastrointestinal Surgery,Yichang Central People's Hospital, The First College of Clinical Medical Science, China Three Gorges University, Yichang, Hubei 443000, P.R. China, Department of Radiology, Yichang Central People's Hospital, The First College of Clinical Medical Science, China Three Gorges University, Yichang, Hubei 443000, P.R. China
Published online on: March 17, 2023 https://doi.org/10.3892/etm.2023.11892
Article Number: 193
Copyright: © Zhou et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Colon cancer is one of the most common causes of cancer‑associated mortality. Tyrosine 3‑monooxygenase/tryptophan 5‑monooxygenase activation protein β (YWHAB) has been reported to be aberrantly expressed in human colon cancer cells following alltrans retinoic acid treatment. PI3K regulatory subunit 2 (PIK3R2) has also been identified as a gene associated with colon cancer metastasis and tumor progression. The present study aimed to determine the role of YWHAB in colon cancer in addition to its detailed reaction mechanism. The expression levels of YWHAB and PIK3 'A0* R2 before or after transfection of YWHAB interference plasmids or PIK3R2 overexpression plasmids were examined by reverse transcription‑quantitative PCR and western blotting. PI flow cytometry, Cell Counting Kit‑8 and TUNEL assays were performed to measure the extent of cell cycle progression, proliferation and apoptosis. Additionally, the expression levels of G₁‑S cell‑cycle transition regulator cyclin D1 and G₁‑checkpoint CDK inhibitor p21 and apoptosis marker proteins Bcl2 and Bax were assessed using western blotting. Subsequently, the Monarch Initiative database (https://monarchinitiative.org/) predicted the binding of YWHAB and PIK3R2, following which co‑immunoprecipitation assay was utilized to assess their potential interaction. Furthermore, western blotting was performed to examine the expression levels of PI3K/AKT signaling pathway markers. It was revealed that YWHAB expression was upregulated in colon cancer cells compared with HIEC‑6 human intestinal epithelial cells. Functionally, YWHAB depletion by transfection of YWHAB interference plasmids was demonstrated to suppress the proliferation of colon cancer cells whilst promoting cell cycle arrest at the G₀/G₁ phase and apoptosis, decreasing cyclin D1 and Bcl2 expression, and increasing p21 and Bax expression. Additionally, YWHAB was verified to bind to PIK3R2 and YWHAB knockdown decreased PIK3R2 expression. PIK3R2 overexpression by transfection of PIK3R2 overexpression plasmids reversed the effects of YWHAB knockdown on cell proliferation, cycle arrest, apoptosis, and apoptotic and cell cycle proteins in colon cancer cells. YWHAB knockdown reduced the levels of p‑PI3K/PI3K and p‑AKT/AKT and PIK3R2 overexpression also reversed the effects of YWHAB knockdown on the expression of PI3K/AKT signaling markers. In conclusion, these data suggest that YWHAB can activate the PI3K/AKT signaling pathway and participate in the malignant progression of colon cancer by targeting PIK3R2, which provides novel insights into the mechanism of colon cancer.

View Figures

View References

1	Haggar FA and Boushey RP: Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg. 22:191–197. 2009.PubMed/NCBI View Article : Google Scholar
2	Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC, Cercek A, Smith RA and Jemal A: Colorectal cancer statistics, 2020. CA Cancer J Clin. 70:145–164. 2020.PubMed/NCBI View Article : Google Scholar
3	Mojtahedi Z, Mohmedi M, Rahimifar S, Erfani N, Hosseini SV and Ghaderi A: Programmed death-1 gene polymorphism (PD-1.5 C/T) is associated with colon cancer. Gene. 508:229–232. 2012.PubMed/NCBI View Article : Google Scholar
4	Zhang Y, Wu Y, Gong ZY, Ye HD, Zhao XK, Li JY, Zhang XM, Li S, Zhu W, Wang M, et al: Distinguishing rectal cancer from colon cancer based on the support vector machine method and RNA-sequencing data. Curr Med Sci. 41:368–374. 2021.PubMed/NCBI View Article : Google Scholar
5	Siegel RL, Miller KD and Jemal A: Cancer statistics, 2017. CA Cancer J Clin. 67:7–30. 2017.PubMed/NCBI View Article : Google Scholar
6	Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. 2018.PubMed/NCBI View Article : Google Scholar
7	Labianca R, Beretta GD, Kildani B, Milesi L, Merlin F, Mosconi S, Pessi MA, Prochilo T, Quadri A, Gatta G, et al: Colon cancer. Crit Rev Oncol Hematol. 74:106–133. 2010.PubMed/NCBI View Article : Google Scholar
8	Rosen AW, Degett TH and Gögenur I: Individualized treatment of colon cancer. Ugeskr Laeger. 178(V11150916)2016.PubMed/NCBI(In Danish).
9	Bellizzi A, Sebastian S, Ceglia P, Centonze M, Divella R, Manzillo EF, Azzariti A, Silvestris N, Montemurro S, Caliandro C, et al: Co-expression of CD133(+)/CD44(+) in human colon cancer and liver metastasis. J Cell Physiol. 228:408–415. 2013.PubMed/NCBI View Article : Google Scholar
10	van Hemert MJ, Steensma HY and van Heusden GP: 14-3-3 proteins: Key regulators of cell division, signalling and apoptosis. Bioessays. 23:936–946. 2001.PubMed/NCBI View Article : Google Scholar
11	Mackintosh C: Dynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes. Biochem J. 381:329–342. 2004.PubMed/NCBI View Article : Google Scholar
12	Hua Y, Wang H, Wang H, Wu X, Yang L, Wang C, Li X, Jin Y, Li M, Wang L, et al: Circular RNA Circ_0006282 promotes cell proliferation and metastasis in gastric cancer by regulating microRNA-144-5p/tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein β axis. Cancer Manag Res. 13:815–827. 2021.PubMed/NCBI View Article : Google Scholar
13	Zhang X, Zhang Q, Zhang K, Wang F, Qiao X and Cui J: Circ SMARCA5 inhibited tumor metastasis by interacting with SND1 and downregulating the YWHAB gene in cervical cancer. Cell Transplant. 30(963689720983786)2021.PubMed/NCBI View Article : Google Scholar
14	Ahluwalia P, Mondal AK, Bloomer C, Fulzele S, Jones K, Ananth S, Gahlay GK, Heneidi S, Rojiani AM, Kota V and Kolhe R: Identification and clinical validation of a novel 4 gene-signature with prognostic utility in colorectal cancer. Int J Mol Sci. 20(3818)2019.PubMed/NCBI View Article : Google Scholar
15	Gao J, Zhou XL, Kong RN, Ji LM, He LL and Zhao DB: microRNA-126 targeting PIK3R2 promotes rheumatoid arthritis synovial fibro-blasts proliferation and resistance to apoptosis by regulating PI3K/AKT pathway. Exp Mol Pathol. 100:192–198. 2016.PubMed/NCBI View Article : Google Scholar
16	Xiao J, Lin HY, Zhu YY, Zhu YP and Chen LW: MiR-126 regulates proliferation and invasion in the bladder cancer BLS cell line by targeting the PIK3R2-mediated PI3K/Akt signaling pathway. Onco Targets Ther. 9:5181–5193. 2016.PubMed/NCBI View Article : Google Scholar
17	Xi T, Jin F, Zhu Y, Wang J, Tang L, Wang Y, Liebeskind DS and He Z: MicroRNA-126-3p attenuates blood-brain barrier disruption, cerebral edema and neuronal injury following intracerebral hemorrhage by regulating PIK3R2 and Akt. Biochem Biophys Res Commun. 494:144–151. 2017.PubMed/NCBI View Article : Google Scholar
18	Dornan GL and Burke JE: Molecular mechanisms of human disease mediated by oncogenic and primary immunodeficiency mutations in class IA phosphoinositide 3-kinases. Front Immunol. 9(575)2018.PubMed/NCBI View Article : Google Scholar
19	Cortés I, Sánchez-Ruíz J, Zuluaga S, Calvanese V, Marqués M, Hernández C, Rivera T, Kremer L, González-García A and Carrera AC: p85β phosphoinositide 3-kinase subunit regulates tumor progression. Proc Natl Acad Sci USA. 109:11318–11323. 2012.PubMed/NCBI View Article : Google Scholar
20	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
21	Yaghoubi A, Khazaei M, Avan A, Hasanian SM and Soleimanpour S: The bacterial instrument as a promising therapy for colon cancer. Int J Colorectal Dis. 35:595–606. 2020.PubMed/NCBI View Article : Google Scholar
22	Gao F, Xu T, Wang X, Zhong S, Chen S, Zhang M, Zhang X, Shen Y, Wang X, Xu C and Shen Z: CIP2A mediates fibronectin-induced bladder cancer cell proliferation by stabilizing beta-catenin. J Exp Clin Cancer Res. 36(70)2017.PubMed/NCBI View Article : Google Scholar
23	Kaczanowski S: Apoptosis: its origin, history, maintenance and the medical implications for cancer and aging. Phys Biol. 13(031001)2016.PubMed/NCBI View Article : Google Scholar
24	Pistritto G, Trisciuoglio D, Ceci C, Garufi A and D'Orazi G: Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies. Aging (Albany NY). 8:603–619. 2016.PubMed/NCBI View Article : Google Scholar
25	Ahmad I, Fakhri S, Khan H, Jeandet P, Aschner M and Yu ZL: Targeting cell cycle by beta-carboline alkaloids in vitro: Novel therapeutic prospects for the treatment of cancer. Chem Biol Interact. 330(109229)2020.PubMed/NCBI View Article : Google Scholar
26	Manchado E, Guillamot M and Malumbres M: Killing cells by targeting mitosis. Cell Death Differ. 19:369–377. 2012.PubMed/NCBI View Article : Google Scholar
27	de Castro Sant' Anna C, Junior AGF, Soares P, Tuji F, Paschoal E, Chaves LC and Burbano RR: Molecular biology as a tool for the treatment of cancer. Clin Exp Med. 18:457–464. 2018.PubMed/NCBI View Article : Google Scholar
28	Herzig DO and Tsikitis VL: Molecular markers for colon diagnosis, prognosis and targeted therapy. J Surg Oncol. 111:96–102. 2015.PubMed/NCBI View Article : Google Scholar
29	Xu C, Du Z, Ren S, Liang X and Li H: MiR-129-5p sensitization of lung cancer cells to etoposide-induced apoptosis by reducing YWHAB. J Cancer. 11:858–866. 2020.PubMed/NCBI View Article : Google Scholar
30	Singh AN and Sharma N: Quantitative SWATH-based proteomic profiling for identification of mechanism-driven diagnostic biomarkers conferring in the progression of metastatic prostate cancer. Front Oncol. 10(493)2020.PubMed/NCBI View Article : Google Scholar
31	Liu Y, Qin Z, Cai L, Zou L, Zhao J and Zhong F: Selection of internal references for qRT-PCR assays of human hepatocellular carcinoma cell lines. Biosci Rep. 37:2017.PubMed/NCBI View Article : Google Scholar
32	Huang KC, Huang TW, Chuang PY, Yang TY and Chang SF: Zoledronate induces cell cycle arrest and differentiation by upregulating p21 in mouse MC3T3-E1 preosteoblasts. Int J Med Sci. 16:751–756. 2019.PubMed/NCBI View Article : Google Scholar
33	Mansilla SF, de la Vega MB, Calzetta NL, Siri SO and Gottifredi V: CDK-independent and PCNA-dependent functions of p21 in DNA replication. Genes (Basel). 11(593)2020.PubMed/NCBI View Article : Google Scholar
34	Rao L, Mak VCY, Zhou Y, Zhang D, Li X, Fung CCY, Sharma R, Gu C, Lu Y, Tipoe GL, et al: p85β regulates autophagic degradation of AXL to activate oncogenic signaling. Nat Commun. 11(2291)2020.PubMed/NCBI View Article : Google Scholar
35	Song L, Xie X, Yu S, Peng F and Peng L: MicroRNA126 inhibits proliferation and metastasis by targeting pik3r2 in prostate cancer. Mol Med Rep. 13:1204–1210. 2016.PubMed/NCBI View Article : Google Scholar
36	Lin J, Zeng C, Zhang J, Song Z, Qi N, Liu X, Zhang Z, Li A and Chen F: EFNA4 promotes cell proliferation and tumor metastasis in hepatocellular carcinoma through a PIK3R2/GSK3β/β-catenin positive feedback loop. Mol Ther Nucleic Acids. 25:328–341. 2021.PubMed/NCBI View Article : Google Scholar
37	Noorolyai S, Shajari N, Baghbani E, Sadreddini S and Baradaran B: The relation between PI3K/AKT signalling pathway and cancer. Gene. 698:120–128. 2019.PubMed/NCBI View Article : Google Scholar
38	Yu JS and Cui W: Proliferation, survival and metabolism: The role of PI3K/AKT/mTOR signalling in pluripotency and cell fate determination. Development. 143:3050–3060. 2016.PubMed/NCBI View Article : Google Scholar
39	Zhang J, Zhang Z, Zhang DY, Zhu J, Zhang T and Wang C: microRNA 126 inhibits the transition of endothelial progenitor cells to mesenchymal cells via the PIK3R2-PI3K/Akt signalling pathway. PLoS One. 8(e83294)2013.PubMed/NCBI View Article : Google Scholar